×
About 20,038 results

ALLMedicine™ Cannabis Center

Research & Reviews  6,715 results

Multiple clinical risks for cannabis users during the COVID-19 pandemic
https://ascpjournal.biomedcentral.com/articles/10.1186/s13722-021-00214-0
Addiction Science & Clinical Practice; Borgonhi, E.M. et. al.

Jan 20th, 2021 - The pandemic caused by Sars-CoV-2 (COVID-19) has been a great concern for public and mental health systems worldwide. The identification of risk groups is essential for the establishment of preventive and therapeutic strategies, as for substance u...

Societal Costs and Outcomes of Medical and Recreational Marijuana Policies in the Unite...
https://doi.org/10.1177/10775587211067315
Medical Care Research and Review : MCRR; French MT, Zukerberg J et. al.

Jan 25th, 2022 - Significant support exists in the United States for legalization of marijuana/cannabis. As of 2021, 36 states and four territories approved the legalization of medical cannabis via medical marijuana laws (MMLs), and 15 states and District of Colum...

Using Decision Trees to Identify Salient Predictors of Cannabis-Related Outcomes.
https://doi.org/10.1080/02791072.2021.2014081
Journal of Psychoactive Drugs; Schwebel FJ, Richards DK et. al.

Jan 25th, 2022 - Cannabis use continues to escalate among emerging adults and college attendance may be a risk factor for use. Severe cases of cannabis use can escalate to a cannabis use disorder, which is associated with worse psychosocial functioning. Predictors...

Adolescent Substance Use Prevention: Long-Term Benefits of School Engagement.
https://doi.org/10.1111/josh.13133
The Journal of School Health; Lee H, Henry KL

Jan 25th, 2022 - To determine if school engagement is a viable target for early prevention of adolescent substance use, this study investigated whether school engagement in early adolescence (ages 12-14) is a cause of alcohol and cannabis use during middle to late...

Is the effect of cognitive reserve in longitudinal outcomes in first-episode psychoses ...
https://doi.org/10.1016/j.jad.2022.01.077
Journal of Affective Disorders; Amoretti S, Verdolini N et. al.

Jan 24th, 2022 - Cognitive reserve (CR) is a protective factor against cognitive and functional impairment in first-episode psychosis (FEP). The aim of this study was to evaluate the differences in clinical presentation according to the use of cannabis (cannabis u...

see more →

Guidelines  7 results

Multiple clinical risks for cannabis users during the COVID-19 pandemic
https://ascpjournal.biomedcentral.com/articles/10.1186/s13722-021-00214-0
Addiction Science & Clinical Practice; Borgonhi, E.M. et. al.

Jan 20th, 2021 - The pandemic caused by Sars-CoV-2 (COVID-19) has been a great concern for public and mental health systems worldwide. The identification of risk groups is essential for the establishment of preventive and therapeutic strategies, as for substance u...

Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline.
https://doi.org/10.1136/bmj.n2040
BMJ (Clinical Research Ed.); Busse JW, Vankrunkelsven P et. al.

Sep 10th, 2021 - What is the role of medical cannabis or cannabinoids for people living with chronic pain due to cancer or non-cancer causes? Chronic pain is common and distressing and associated with considerable socioeconomic burden globally. Medical cannabis is...

Canadian Cardiovascular Society/Canadian Cardiac Transplant Network Position Statement ...
https://doi.org/10.1016/j.cjca.2019.12.025
The Canadian Journal of Cardiology; Chih S, McDonald M et. al.

Mar 9th, 2020 - Significant practice-changing developments have occurred in the care of heart transplantation candidates and recipients over the past decade. This Canadian Cardiovascular Society/Canadian Cardiac Transplant Network Position Statement provides evid...

How can primary care practitioners address substance use by adolescents? A position pap...
https://doi.org/10.1007/s00431-020-03596-6
European Journal of Pediatrics; Michaud PA, Bélanger R et. al.

Feb 23rd, 2020 - The objective of this article is to review how primary care providers - paediatricians, family practitioners, nurse practitioners - could address the use of substances by adolescents and respond to problematic behaviours and situations. Given the ...

Patient Counseling Guidelines for the Use of Cannabis for the Treatment of Chemotherapy...
https://doi.org/10.1080/15360288.2019.1598531
Journal of Pain & Palliative Care Pharmacotherapy; Makary P, Parmar JR et. al.

May 10th, 2019 - The use of cannabis medications has grown in recent years for the symptomatic relief of chemotherapy-induced nausea/vomiting (CINV) and chronic pain (cancer-related and non-cancer-related). As states legalize the use of cannabis, it is important f...

see more →

Drugs  24 results see all →

Clinicaltrials.gov  185 results

Multiple clinical risks for cannabis users during the COVID-19 pandemic
https://ascpjournal.biomedcentral.com/articles/10.1186/s13722-021-00214-0
Addiction Science & Clinical Practice; Borgonhi, E.M. et. al.

Jan 20th, 2021 - The pandemic caused by Sars-CoV-2 (COVID-19) has been a great concern for public and mental health systems worldwide. The identification of risk groups is essential for the establishment of preventive and therapeutic strategies, as for substance u...

Cannabinoids, Learning, and Memory
https://clinicaltrials.gov/ct2/show/NCT02407808

Jan 21st, 2022 - This study will be achieved by studying the acute effects of delta-9-tetrahydrocannabinol (THC), the main psychoactive component of cannabis and a cannabinoid-1 receptor (CB1R) agonist, on a wide range of memory tasks in healthy human subjects.

Role of CBD in Regulating Meal Time Anxiety in Anorexia Nervosa
https://clinicaltrials.gov/ct2/show/NCT04878627

Jan 21st, 2022 - No studies of cannabidiol (CBD) have focused on Anorexia Nervosa (AN). Dose, side effects, tolerability, acceptability of pure CBD in AN must be established. The current study is an important first step in the investigation of CBD for AN. Cannabis...

Patients' Attitudes Toward and Experiences With Buprenorphine Treatment
https://clinicaltrials.gov/ct2/show/NCT05121428

Jan 20th, 2022 - The primary objective of this study is to better understand patients' attitudes and experiences during office-based opioid treatment (OBOT) in the COVID-19 pandemic. This study specifically aims to evaluate attitudes and experiences of people pres...

Impact of CBD-Rich Oil on Aversive Memory Reconsolidation
https://clinicaltrials.gov/ct2/show/NCT04726475

Jan 19th, 2022 - Preclinical experiments demonstrate that isolated cannabidiol (CBD), the non-psychotomimetic constituent of the Cannabis sativa plant, disrupts reconsolidation of aversive memories conditioned in the laboratory when administered within the memory ...

see more →

News  1,082 results

Multiple clinical risks for cannabis users during the COVID-19 pandemic
https://ascpjournal.biomedcentral.com/articles/10.1186/s13722-021-00214-0
Addiction Science & Clinical Practice; Borgonhi, E.M. et. al.

Jan 20th, 2021 - The pandemic caused by Sars-CoV-2 (COVID-19) has been a great concern for public and mental health systems worldwide. The identification of risk groups is essential for the establishment of preventive and therapeutic strategies, as for substance u...

Not Your Parents' Pot: Teen Cannabis Use Raises Red Flags
https://www.medscape.com/viewarticle/967008

Jan 21st, 2022 - Marijuana. Mary Jane. Weed. Pot. Skunk. Shake, shatter, and pre-rolls. No matter what you call it, thanks to expanded medical and recreational availability of cannabis in the United States, a growing number of adolescents are using the drug — with...

Survey: Medical Cannabis Use for Skin Conditions Lags Behind Interest, Acceptance
https://www.medscape.com/viewarticle/966921

Jan 20th, 2022 - A majority of adults support the use of medical cannabis for the treatment of skin conditions, but relatively few have actually tried such a product, according to the results of a recent survey. Almost 89% of respondents were in favor of medical c...

Trial Will Test Synthetic Cannabinoid for Weight Loss in Obesity
https://www.medscape.com/viewarticle/966836

Jan 19th, 2022 - Researchers are about to enroll the first patient in a pilot study of potential weight loss with nabilone — a manufactured cannabinoid similar to the active component of the marijuana (cannabis) plant. Although cannabis is associated with the "mun...

Dramatic Increase in Driving High After Cannabis Legalization
https://www.medscape.com/viewarticle/966722

Jan 17th, 2022 - Since Canada legalized marijuana in 2018, there has been a dramatic increase in the number individuals driving while high, new research shows. Investigators studied over 4000 drivers treated after a motor vehicle collision in British Columbia trau...

see more →

Patient Education  2 results see all →